*Correspondence: Eng Wee Chua, [email protected] This article was submitted to Gastrointestinal and Hepatic Pharmacology, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Exclusion criteria included previous VTE, using a DOAC or had AF, as well as if patients were on both medications
Drug Distribution Gross Profits, Big Three Wholesalers, Total and Annual Change, 2021 to 2025 Exhibit 90: Estimated Buy-Side and Sell-Side Contributions to Wholesalers Gross Margin, 2025 Exhibit 91: Estimated Drug Distribution Gross Margin, by Drug and Customer Type, 2025 Exhibit 92: Revenues and Gross Profits, Big Three Wholesalers, by Type of Drug, 2025 Exhibit 93: Median Wholesaler Sell-Side Discount for Generic Drugs Sold to Retail Pharmacies, by Number of Manufacturers, 2025 Exhibit 94: Path of Wholesaler Gross Profits, Brand vs
The claims-based methodology proposed in the CY 2026 PFS proposed rule for identification of 340B units is exclusively for use in the Medicare Part D Drug Inflation Rebate Program to implement the statutory requirement at section 1860D-14B(b)(1)(B) of the Act to exclude from the calculation of Part D inflation rebates units for which a manufacturer provided a discount under the 340B Program
High MCH means red blood cells contain more haemoglobin than normal, which may indicate macrocytic anaemia caused by vitamin B12 or folate deficiency
High-Throughput Screening Identifies Two Classes of Antibiotics as Radioprotectors: Tetracyclines and Fluoroquinolones
